Bell Investment Advisors’s Colgate-Palmolive CL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$32.4K Buy
380
+52
+16% +$4.63K 0.01% 331
2025
Q4
$25.9K Sell
328
-174
-35% -$13.6K ﹤0.01% 373
2025
Q3
$40.1K Buy
502
+1
+0.2% +$85 0.01% 272
2025
Q2
$45.5K Buy
501
+38
+8% +$3.47K 0.01% 262
2025
Q1
$43.4K Sell
463
-1
-0.2% -$90 0.01% 241
2024
Q4
$42.2K Sell
464
-15
-3% -$1.43K 0.01% 242
2024
Q3
$49.7K Hold
479
0.01% 226
2024
Q2
$46.5K Buy
479
+6
+1% +$553 0.01% 222
2024
Q1
$42.6K Hold
473
0.01% 229
2023
Q4
$37.7K Sell
473
-143
-23% -$10.8K 0.01% 230
2023
Q3
$43.8K Sell
616
-72
-10% -$5.38K 0.01% 189
2023
Q2
$53K Buy
688
+6
+0.9% +$464 0.01% 159
2023
Q1
$51.3K Sell
682
-95
-12% -$7.06K 0.01% 159
2022
Q4
$61.2K Sell
777
-19
-2% -$1.42K 0.02% 142
2022
Q3
$56K Buy
796
+46
+6% +$3.61K 0.02% 124
2022
Q2
$60K Buy
+750
New +$58.6K 0.02% 118
2021
Q4
$61K Buy
715
+68
+11% +$5.31K 0.02% 136
2021
Q3
$49K Buy
+647
New +$51.4K 0.01% 148

Other funds holding CL

Bell Investment Advisors's CL Position: Q1 2026 in Review

Bell Investment Advisors increased its Colgate-Palmolive (CL) stake by 16% in Q1 2026, buying an estimated $4.63K and bringing the position to 380 shares worth $32.4K. The position accounts for 0.01% of the portfolio, ranked #331.

Bell Investment Advisors first reported a position in CL in Q3 2021 and has held it in 18 quarters since. The position peaked at $61.2K in Q4 2022. 1,947 funds tracked by Wall St. Rank hold CL as of Q1 2026.

  • Bell Investment Advisors held 380 shares of Colgate-Palmolive worth $32.4K as of Q1 2026.
  • Bell Investment Advisors bought 52 Colgate-Palmolive shares in Q1 2026, an estimated $4.63K.
  • Colgate-Palmolive made up 0.01% of Bell Investment Advisors's portfolio in Q1 2026, its #331 holding.
  • Bell Investment Advisors first reported a position in Colgate-Palmolive in Q3 2021 and has held it in 18 quarters since.
  • Bell Investment Advisors's Colgate-Palmolive position peaked at $61.2K in Q4 2022.
  • 1,947 funds tracked by Wall St. Rank held Colgate-Palmolive as of Q1 2026.

Based on Bell Investment Advisors's 13F filing for Q1 2026, filed 17 Apr 2026.